HEATON MOOR MEDICAL GROUP
32 HEATON MOOR ROAD, STOCKPORTStroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 77 | 81 | 95.1% | |
STROKE 9 | 2006 | 98 | 103 | 95.1% | |
Stroke 12 | 2007 | 103 | 106 | 97.2% | |
Stroke 12 | 2008 | 102 | 109 | 93.6% | |
Stroke 12 | 2009 | 96 | 101 | 95.0% | |
Stroke 12 | 2010 | 108 | 113 | 95.6% | |
STROKE 12 | 2011 | 121 | 132 | 91.7% | |
STROKE 12 | 2012 | 125 | 132 | 94.7% | |
STROKE 12 | 2013 | 118 | 126 | 93.7% | |
STIA007 | 2014 | 128 | 131 | 97.7% | |
STIA007 | 2015 | 142 | 142 | 100.0% | |
STIA007 | 2016 | 285 | 289 | 98.6% | |
STIA007 | 2017 | 287 | 294 | 97.6% | |
STIA007 | 2018 | 371 | 379 | 97.9% | |
STIA007 | 2019 | 415 | 416 | 99.8% | |
STIA007 | 2020 | 430 | 436 | 98.6% | |
STIA007 | 2021 | 430 | 440 | 97.7% | |
STIA007 | 2022 | 441 | 454 | 97.1% | |
STIA007 | 2023 | 542 | 546 | 99.3% |